TY  - JOUR
A1  - Kunzmann, S.
A1  - Ngyuen, T.
A1  - Stahl, A.
A1  - Walz, J. M.
A1  - Nentwich, M. M.
A1  - Speer, C. P.
A1  - Ruf, K.
T1  - Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti – a case report
JF  - BMC Pediatrics
N2  - Background
Incontinentia Pigmenti is a rare disease affecting multiple organs. Fifty of patients show affection of the eye with retinopathy and possible amaurosis being the worst outcome. Treatment has commonly been panretinal laser coagulation but intravitreal application of bevacizumab as VEGF-inhibitor has shown to effectively suppress retinal neovascularization.

Case presentation
A six-week-old female infant with Incontinentia Pigmenti developed a foudroyant necrotizing enterocolitis shortly after intravitreal injection of bevazicumab due to a retinopathy with impending tractional detachment of the left eye. Since the onset of abdominal symptoms occurred immediately after the intravitreal application, a link between the two events seemed likely. Sequential analyses of the VEGF serum concentrations showed a massive suppression of endogenous VEGF with only a very slow recovery over weeks. Such a severe systemic adverse event has not been reported after intravitreal treatment with bevacizumab in an infant.

Conclusion
This case report shows a relevant systemic uptake of bevacizumab after intravitreal application as suppressed VEGF levels show. There seems to be a connection between suppressed VEGF levels and the onset of necrotizing enterocolitis. Therefore, treatment with bevacizumab should be carefully considered and further research is needed to assess this drug’s safety profile.
KW  - Necrotizing enterocolitis
KW  - Incontinentia pigmenti
KW  - Bevacizumab
KW  - Retinopathy
KW  - VEGF
Y1  - 2019
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-201024
VL  - 19
ER  - 
TY  - JOUR
A1  - Wieber, M.
A1  - Walz, J.
A1  - Burschka, Christian
T1  - Organostibonsäureester. II [1]: Darstellung und Eigenschaften von Methanstibonsäureestern. Struktur von Di-μ-methoxy-bis[dibromo-methoxy-methyl-antimon(V)]
N2  - Dimere alkoxyverbrückte Verbindungen des Typs [CH\(_3\)SbX\(_2\)(OR)(μ-OR)]\(_2\) (X = Cl, Br; R = CH\(_3\), C\(_2\)H\(_5\)) können durch Oxidation von CH\(_3\)Sb(OR)\(_2\) mit Br\(_2\) oder S0\(_2\)Cl\(_2\) in CH\(_2\)Cl\(_2\) unterhalb -60°C als lichtempfindliche kristalline Feststoffe erhalten werden. Die Struktur der Verbindung [CH\(_3\)SbBr\(_2\)(OCH\(_3\))(μ-OCH\(_3\))]\(_2\) konnte mittels Röntgenstrukturanalyse bestimmt werden. Umsetzungen mit Natriumalkoholaten in den entsprechenden Alkoholen bei 0°C führen zu dimeren Tetraalkoxymethylstiboranen. Austauschreaktionen von Tetramethoxymethylstiboran mit Ethanol ergeben das Ethoxyderivat und mit Diolen symmetrische spirocyclische Methanstibonsäureester.
N2  - Dimeric alkoxy-bridged compounds of the type [CH\(_3\)SbX\(_2\)(OR)(μ-OR)]\(_2\) (X = Cl, Br; R = CH\(_3\), C\(_2\)H\(_5\)) are prepared by oxidation of CH\(_3\)Sb(OR)\(_2\) with Br\(_2\) or S0\(_2\)Cl\(_2\) in CH\(_2\)Cl\(_2\) below -60°C as light sensitive erystals. The structure of [CH\(_3\)SbBr\(_2\)(OCH\(_3\))(μ-OCH\(_3\))]\(_2\) was determined by X-Ray analysis. By reaction with sodium alkoxides in the corresponding alcohol at 0°C dimeric tetraalkoxymethylstiboranes are obtained. Exchange reactions of tetramethoxymethylstiborane with ethanol give the ethoxy derivative and with diols symmetrie spirocyclic esters of methanestibonic acid.
KW  - Chemie
Y1  - 1990
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31909
ER  -